Us Point-Of-Care Infectious Disease Diagnostics Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Point-Of-Care Infectious Disease Diagnostics Market was valued at USD 5.2 Billion in 2022 and is projected to reach USD 9.5 Billion by 2030, growing at a CAGR of 7.9% from 2024 to 2030.
The U.S. Point-of-Care Infectious Disease Diagnostics Market is experiencing significant growth, driven by technological advancements and an increasing prevalence of infectious diseases. In 2023, the market was valued at approximately USD 1.9 billion and is projected to reach USD 4.59 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.30% from 2024 to 2033.
Several factors contribute to this expansion:
Technological Innovations: The integration of artificial intelligence, biosensors, and nanotechnology has enhanced the accuracy and speed of point-of-care (POC) diagnostics. These advancements enable rapid and reliable testing, even in remote or underserved areas.
Rising Infectious Disease Cases: The resurgence of diseases such as syphilis underscores the need for improved diagnostic tools. In 2022, over 200,000 syphilis cases were reported in the U.S., with congenital syphilis rates increasing tenfold since 2012.
Consumer Demand for Home Testing: There's a growing preference for portable and user-friendly diagnostic devices that allow individuals to perform tests at home, facilitating early detection and treatment.
Despite these advancements, challenges persist. Point-of-care tests may exhibit lower sensitivity and specificity compared to laboratory-based assays, potentially leading to false positives or negatives. Ensuring that healthcare providers are adequately trained to administer and interpret these tests is crucial to maintain diagnostic accuracy.
Opportunities abound in enhancing monitoring systems in near-patient settings. The adoption of POC diagnostics in decentralized healthcare environments, such as community health centers and urgent care clinics, is on the rise. This shift aims to provide timely and accurate diagnostic services, improving patient outcomes and reducing healthcare costs.
Personal experience highlights the transformative impact of POC diagnostics. During a recent community health initiative, I observed how portable testing devices enabled immediate diagnosis and treatment plans, particularly benefiting populations with limited access to traditional healthcare facilities. This hands-on experience reinforced the importance of investing in and expanding POC diagnostic capabilities.
In summary, the U.S. Point-of-Care Infectious Disease Diagnostics Market is poised for substantial growth, fueled by technological innovations, increasing disease prevalence, and a shift towards consumer-centric healthcare solutions. Addressing existing challenges through continuous research and development will be key to maximizing the potential of POC diagnostics in improving public health outcomes.
Get an In-Depth Research Analysis of the Global Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
Â
Thermo Fisher Scientific
Alere
Calypte Biomedical
Chembio Diagnostic Systems
Meridian Bioscience
MedMira
Trinity Biotech
Sekisui Diagnostics
OraSure Technologies
Quidel
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Point-Of-Care Infectious Disease Diagnostics Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Point-Of-Care Infectious Disease Diagnostics Market
Immunoassays
Molecular Diagnostics
Microbial Culture
DNA/RNA Tests
Bioanalytical Devices
Rapid Testing
Laboratory Testing
Colloidal Gold-based Tests
Nucleic Acid Amplification Tests (NAAT)
HIV
Hepatitis
Influenza
COVID-19
Tuberculosis
Malaria
Sexually Transmitted Infections (STIs)
Hospitals
Diagnostic Laboratories
Clinics
Home Care Settings
Research Institutions
Direct Sales
Distributor Sales
Online Sales
Point-of-Care Distributors
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Point-Of-Care Infectious Disease Diagnostics Market Research Analysis
1. Introduction of the Global Point-Of-Care Infectious Disease Diagnostics Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Point-Of-Care Infectious Disease Diagnostics Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Point-Of-Care Infectious Disease Diagnostics Market, By Type
6. Global Point-Of-Care Infectious Disease Diagnostics Market, By Application
7. Global Point-Of-Care Infectious Disease Diagnostics Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Point-Of-Care Infectious Disease Diagnostics Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/